Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anti-Microbialvior BioteQ CoROCO:6864 -0.46%61 Days Inventory is 1,259.87 as of Dec. 2025, which is 20% above its 10-year median of 1,045.87. GuruFocus rates ROCO:6864 with a GF Score™ of 61/100 and a GF Value™ of NT$25.46 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Anti-Microbialvior BioteQ Co ranks worse than 94.98% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Anti-Microbialvior BioteQ Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.14.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Anti-Microbialvior BioteQ Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 4.38.
Anti-Microbialvior BioteQ Co (ROCO:6864) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Anti-Microbialvior BioteQ Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Anti-Microbialvior BioteQ Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Anti-Microbialvior BioteQ Co Days Inventory Related Terms
Anti-Microbialvior BioteQ Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6864 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anti-Microbialvior BioteQ Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Anti-Microbialvior BioteQ Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anti-Microbialvior BioteQ Co (ROCO:6864) has a Days Inventory of 1,259.87 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Anti-Microbialvior BioteQ Co and its competitors. This is 20% above median its historical median of 1,045.87. Over the past decade, Anti-Microbialvior BioteQ Co's Days Inventory has ranged from 151.33 to 7,469.15. According to the industry distribution chart, Anti-Microbialvior BioteQ Co ranks #606 out of 638 companies in the Biotechnology industry, placing it in the top 95%.
Is Anti-Microbialvior BioteQ Co's Days Inventory too high?
Anti-Microbialvior BioteQ Co's current Days Inventory of 1,259.87 is 20% above median its 10-year median of 1,045.87. Over the past 10 years, this metric has ranged from a low of 151.33 to a high of 7,469.15. The Biotechnology industry median Days Inventory is 183.20. Anti-Microbialvior BioteQ Co's value of 1,259.87 is 587.7% above this industry median. Based on the distribution chart, Anti-Microbialvior BioteQ Co ranks #606 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Anti-Microbialvior BioteQ Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anti-Microbialvior BioteQ Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anti-Microbialvior BioteQ Co ranks #606 out of 638 companies for Days Inventory. This places Anti-Microbialvior BioteQ Co in the lower half of its industry. The industry median Days Inventory is 183.20. Anti-Microbialvior BioteQ Co's value of 1,259.87 is 587.7% above this benchmark. Historically, Anti-Microbialvior BioteQ Co's own Days Inventory has ranged from 151.33 to 7,469.15 over the past decade. While the company's 10-year median is 1,045.87 vs. the industry median of 183.20, Anti-Microbialvior BioteQ Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anti-Microbialvior BioteQ Co's current Days Inventory of 1,259.87 is 587.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Anti-Microbialvior BioteQ Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anti-Microbialvior BioteQ Co's current Days Inventory is 1,259.87, which is 20% above median its own 10-year median of 1,045.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anti-Microbialvior BioteQ Co stock overvalued right now?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co (ROCO:6864) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$25.46, compared to a current price of NT$42.85 — trading 68.3% above its estimated fair value. The current Days Inventory is 1,259.87, which is 20% above median its 10-year median of 1,045.87 and 587.7% above the Biotechnology industry median of 183.20. Anti-Microbialvior BioteQ Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Anti-Microbialvior BioteQ Co (ROCO:6864), the current Days Inventory is 1,259.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be overvalued.
The current stock price of NT$42.85 is trading 68.3% above its estimated GF Value™ of NT$25.46.
GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Overvalued.
Key valuation signals for ROCO:6864:
Days Inventory: 1,259.87 (20% above median its 10-year median of 1,045.87)
GF Value™: NT$25.46 vs. price of NT$42.85 (68.3% above fair value)
Industry Position: 587.7% above the Biotechnology median (#606 of 638)
No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6864 has been successfully added to your 
